Comment: Transdermal Fentanyl

Abstract

Get full access to this article

View all access options for this article.

References

Yee

Lopez

. Transdermal fentanyl. Ann Pharmacother 1992; 26: 1393–9.

Package insert. Duragesic (transdermal fentanyl). Titusville, NJ: Janssen Pharmaceutica, 1992.

Miser

Narang

Dothage

Young

Sindelar

Miser

. Transdermal fentanyl for pain control in patients with cancer. Pain 1989; 37: 15–21.

Lavy

Jacobs

Johnson

Schultz

Kowal

Meisler

Transdermal fentanyl: pain and quality of life effects. Proc Am Soc Clin Oncol 1988; 7: 292.

Simmonds

Blain

Richenbaucher

A new approach to the administration of opiates: TTS (fentanyl) in the management of pain in patients with cancer. J Pain Symptom Manage 1988; 3 (suppl): S–18.

Simmonds

Payne

Richenbaucher

Moran

. TTS (fentanyl) to the management of pain in patients with cancer (abstract). Proc Am Soc Clin Oncol 1989; 8: 324.

Zech

DFJ

Grond

SUA

Lynch

Dauer

Stollenwerk

Lehmann

. Transdermal fentanyl and initial dose-finding with patient controlled analgesia in cancer pain: a pilot study with 20 terminally ill cancer patients. Pain 1992; 50: 293–301.

Herbst

Strause

. Transdermal fentanyl use in hospice home-care patients with chronic cancer pain. J Pain Symptom Manage 1992; 7 (suppl): S-54–7.

Maves

Barcellos

. Management of cancer pain with transdermal fentanyl: phase IV trial, University of Iowa. J Pain Symptom Manage 1992; 7 (suppl): S-58–62.

10.

Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center. J Pain Symptom Manage 1992; 7 (suppl): S-45–7.

11.

Levy

Rosen

Kedziera

. Transdermal fentanyl: seeding trial to patients with chronic cancer pain. J Pain Symptom Manage 1992; 7 (suppl): S-48–50.

12.

Patt

Hogan

. Transdermal fentanyl for chronic cancer pain: detailed case reports and the influence of confounding factors. J Pain Symptom Manage 1992; 7 (suppl): S-51–3.